Announce on behalf of major subsidiary Cotton
Field Organic Co., Ltd.on matters related to the full
non-physical issuance of shares
Date of events
2022/08/17
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/08/17
2.Company name:Cotton Field Organic Co., Ltd.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):subsidiary
4.Reciprocal shareholding ratios:72.66% owned by Microbio CO.,LTD.
5.Cause of occurrence:The board of directors of the subsidiary Cotton
Field Organic Co., Ltd.resolved to replace shares by non-physical issuance
on 2022/08/17.
6.Countermeasures:None
7.Any other matters that need to be specified:
(i)The company has issued 58,386,672 common shares, the par value per
share is NT$10, totaling NT$583,866,720.The ratio of the stock
registration to non-physical is 1:1.Its rights and obligations are
as same as the shares originally issued after the non-physical
issuance.
(ii)The record date and relevant schedule for issuing the non-physical
stock:
(1)Last transfer date of original shares:2022/08/24
(2)Book closure period of original shares:From 2022/08/25 to 2022/08/29
(3)The benchmark date for stock transferring to non-physical issuance:
2022/08/29.
(iii)The relevant procedures and matters are authorized by the chairman.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Microbio Co. Ltd. published this content on 17 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 August 2022 09:23:03 UTC.
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.